The global oncology market was estimated to be worth US$ 286.04 billion in 2021 and is projected to expand to more than US$ 581.25 billion by 2030, with a notable CAGR of 8.2% predicted to occur between 2022 and 2030.
The worldwide oncology market is expanding as a result of the rising oncology burden globally caused by rising alcohol and tobacco use. In its report GLOBOCAN, the International Agency for Research on Cancer (IARC) estimates that abo
In its GLOBOCAN report, the International Agency for Research on Cancer (IARC) estimates that there were roughly 19.3 million new cases of cancer and 10 million cancer-related deaths worldwide in 2020. 

In 2021, the cancer diagnostic market category accounted for 46.8% of the overall market share. From 2022 to 2030, the hospital segment will expand at a CAGR of 10.9%.
In 2021, the market for breast cancer was worth USD 57.23 billion.
In 2021, the North American area held 46.2% of the global market share.
According to the IARC, global new cancer cases are predicted to increase by 47% between 2020 and 2040. Therefore, it is anticipated that the rising incidence of cancer would encourage the use of oncology diagnostics and oncology treatments everywhere, thereby fostering the expansion of the worldwide oncology market